Inovalon, a leading provider of cloud-based software solutions
empowering data-driven healthcare, welcomed industry trailblazers
and visionary executives to the stage at Empower 2024, sparking
meaningful conversations with leaders from every corner of
healthcare. The annual summit, focused on the intersection of
healthcare and technology, welcomed attendees in Washington, D.C.,
to showcase innovative strategies aimed at improving clinical,
financial, and operational performance.
Kicking off the summit, Keith Dunleavy, M.D.,
CEO and Founder of Inovalon, brought attendees through a
technological innovation journey to highlight AI, machine learning,
and data’s impact on healthcare. Dunleavy shared, “We have an
opportunity to make healthcare better, but we need to fully embrace
the rapid progression of software sophistication and technology. We
need to be willing to take on innovation at a faster, more
uncomfortable pace.”
Applying AI in Healthcare, Today and
Tomorrow AI innovation took center stage at Empower, with
many sessions illustrating its transformative potential across the
healthcare ecosystem. Industry leaders Rajesh Viswanathan, CTO at
Inovalon, Rahul Pathak, VP of Gen AI and AI/ML GTM at AWS (NASDAQ:
AMZN), Vinod Mamtani, VP, AI and Data Science Services at Oracle
Cloud Infrastructure (NYSE: ORCL), and Murali Gandhirajan, Global
Healthcare CTO at Snowflake (NYSE: SNOW), shared their perspectives
on where the biggest opportunities in technology exist and their
vision for how AI will unfold in the future of healthcare. The
panel agreed that AI is a powerful force multiplier poised to
personalize care interactions, automate workflows, and accelerate
drug development. But they were clear: organizations must lean into
these advancements or risk being left behind, and as the industry
embraces emerging technology to assist, augment, and accelerate
outcomes, those who commit will lead the way in delivering more
efficient, impactful care.
Modernizing the Healthcare
System
Former CDC Director, Rochelle Walensky, M.D.,
MPH, joined Inovalon’s Chief Medical Officer, Dr. Paige Killian,
M.D., on stage at Empower to advocate for data modernization across
the healthcare and public health systems. Dr. Walensky provided
first-hand perspective on the data challenges that the U.S. public
health infrastructure faced during the pandemic and other outbreaks
while she worked in the CDC and the difficulties with collecting
and integrating a vast amount of data from various sources and
formats in a timely manner. She emphasized that to get actionable
data before we get past the peak of an outbreak or even the next
pandemic, we must educate and upskill the healthcare workforce in
data analysis and AI. This emphasis on the role of the healthcare
and public health workforce in data modernization was a recurring
theme throughout the conference, with all participants and speakers
agreeing that a modern data strategy serves as the foundation for
any successful public health, AI, or technology strategy.
Maximizing Real-World Evidence and
Utilizing SDOH Data to Improve OutcomesAn additional theme
at Empower was the benefit of unlocking real-world evidence (RWE)
and social drivers of health (SDOH) data to create a more equitable
healthcare ecosystem. While clinical trials are essential for
determining drug safety and efficacy, they are prone to gaps in
understanding the patient’s experience and real-world outcomes.
Industry experts, including Christie Teigland, Ph.D., VP of
Research Science & Advanced Analytics at Inovalon, Todd Sharp,
Head of Strategy & Transformation for Healthcare and Life
Sciences at AWS (NASDAQ: AMZN), and Brett Kay, Director of
Healthcare Quality Strategy at Johnson & Johnson (NYSE: JNJ),
shared strategies for activating RWE and SDOH data to support
vulnerable and underrepresented populations. With SDOH contributing
to up to 80% of health outcomes, these sessions highlighted
opportunities for leveraging data to bridge care gaps and improve
cross-industry collaboration. But first, it was clear there must be
a push to reduce disparate data sources, improve health literacy,
and actively fight against health disparities to improve
representation and care across the healthcare continuum.
The Future of Patient-Centric Cell and
Gene Therapies Cell and gene therapies have transformed
how the healthcare industry treats and potentially cures common and
rare diseases. Kim Tedesco, RPh, Director of Gene & Cell
Therapy Pharmacy Operations at Walgreens (NASDAQ: WBA), welcomed to
the Empower stage the first patient to ever receive a CRISPR
cell-based gene therapy treatment for sickle cell. The patient
advocate brought attendees through her care and treatment journey
while living with the crippling disease through childhood and
adulthood. The session highlighted the miracles of these therapies
and the essential relationships between pharmacies, providers, and
health plans needed to ensure patients receive life-saving
treatments.
Advancing Data-Driven Healthcare: Seven
New Software Solutions and Feature-Set Expansions
Announced
In a continued effort to drive ever-greater
impact across the healthcare continuum, Inovalon unveiled seven new
products and features to help providers, payers, pharmacies, and
life sciences prioritize data-driven healthcare.
The Eligibility Verification Pro solution
improves revenue cycle management by simplifying providers’ ability
to accurately verify patients’ insurance coverage, reducing claims
denials, and improving cash flow. For health plans, Inovalon
announced Converged Provider Enablement to turn cost and
utilization data into actionable insights, Converged Record Review
to automate manual medical record reviews and improve risk score
accuracy, and Converged Outreach Connectors to provide secure,
seamless member data sharing capabilities. Additionally, the
company also launched a Research Network to help health systems and
life sciences organizations accelerate access to clinical trials
and life-saving therapies. Finally, Inovalon is expanding the
feature set of ScriptMed and debuted the new Inovalon Application
Portal to provide customers with a centralized hub to find and
launch all Inovalon ONE® Platform applications.
Additional details on the product news can be
found on Inovalon’s website here:
https://www.inovalon.com/news/inovalon-launches-seven-new-software-solutions-and-feature-set-expansions-to-drive-ever-greater-impact-across-the-healthcare-continuum/.
"Empower 2024 showed us that the technology
revolution poised to transform healthcare isn’t lifetimes away –
it’s right around the corner,” said Eron Kelly, President of
Inovalon. “Inovalon is leading the charge in data-driven healthcare
transformation. Together, with our customers and partners, we are
shifting from a reactive, episodic industry to a more predictive
and preventive system where data, AI, and personalization are
shaping the future of healthcare.”
Experience Empower 2024’s best moments here:
https://www.inovalon.com/empower/. About
Inovalon
Inovalon is a leading provider of cloud-based
SaaS solutions empowering data-driven healthcare. The Inovalon ONE®
Platform brings together national-scale connectivity, real-time
primary source data access, and advanced analytics into a
sophisticated cloud-based platform empowering improved outcomes and
economics across the healthcare ecosystem. The company’s analytics
and capabilities are used by nearly 20,000 customers supporting
more than 53,000 sites of care, and are informed by the primary
source data of more than 85 billion medical events across 1.1
million physicians, 677,000 clinical settings, and 395 million
unique lives. For more information, visit www.inovalon.com.
Contact:Tom PaolellaSr.
Director, Press and Analyst Relations,
InovalonThomas.Paolella@inovalon.com
Oracle (NYSE:ORCL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Oracle (NYSE:ORCL)
Historical Stock Chart
From Nov 2023 to Nov 2024